Trial Profile
An Exploratory Study for AD-810N in Patients with Parkinsonism in Dementia with Lewy Bodies (Phase 2 study)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Jan 2018
Price :
$35
*
At a glance
- Drugs Zonisamide (Primary)
- Indications Dementia; Parkinsonian disorders
- Focus Therapeutic Use
- Sponsors Sumitomo Dainippon Pharma
- 24 Jan 2018 Results published in the Neurology
- 03 Jun 2016 New trial record